TDSGF
Price
$0.08
Change
+$0.01 (+14.29%)
Updated
Jul 2 closing price
Capitalization
13.15M
USAQ
Price
$0.21
Change
-$0.02 (-8.70%)
Updated
Jun 30 closing price
Capitalization
698.66K
Interact to see
Advertisement

TDSGF vs USAQ

Header iconTDSGF vs USAQ Comparison
Open Charts TDSGF vs USAQBanner chart's image
Telo Genomics
Price$0.08
Change+$0.01 (+14.29%)
Volume$100
Capitalization13.15M
QHSLab
Price$0.21
Change-$0.02 (-8.70%)
Volume$6.2K
Capitalization698.66K
TDSGF vs USAQ Comparison Chart in %
Loading...
TDSGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TDSGF vs. USAQ commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TDSGF is a Hold and USAQ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (TDSGF: $0.08 vs. USAQ: $0.21)
Brand notoriety: TDSGF and USAQ are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: TDSGF: 1% vs. USAQ: 46%
Market capitalization -- TDSGF: $13.15M vs. USAQ: $698.66K
TDSGF [@Medical Specialties] is valued at $13.15M. USAQ’s [@Medical Specialties] market capitalization is $698.66K. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TDSGF’s FA Score shows that 0 FA rating(s) are green whileUSAQ’s FA Score has 0 green FA rating(s).

  • TDSGF’s FA Score: 0 green, 5 red.
  • USAQ’s FA Score: 0 green, 5 red.
According to our system of comparison, TDSGF is a better buy in the long-term than USAQ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TDSGF’s TA Score shows that 4 TA indicator(s) are bullish while USAQ’s TA Score has 2 bullish TA indicator(s).

  • TDSGF’s TA Score: 4 bullish, 4 bearish.
  • USAQ’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, TDSGF is a better buy in the short-term than USAQ.

Price Growth

TDSGF (@Medical Specialties) experienced а +16.09% price change this week, while USAQ (@Medical Specialties) price change was -8.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

TDSGF is expected to report earnings on May 27, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TDSGF($13.2M) has a higher market cap than USAQ($699K). TDSGF YTD gains are higher at: -9.172 vs. USAQ (-15.323). USAQ has higher annual earnings (EBITDA): -473.6K vs. TDSGF (-2.59M). TDSGF has more cash in the bank: 721K vs. USAQ (93.1K). TDSGF has less debt than USAQ: TDSGF (40K) vs USAQ (1.63M). USAQ has higher revenues than TDSGF: USAQ (1.24M) vs TDSGF (0).
TDSGFUSAQTDSGF / USAQ
Capitalization13.2M699K1,888%
EBITDA-2.59M-473.6K546%
Gain YTD-9.172-15.32360%
P/E RatioN/AN/A-
Revenue01.24M-
Total Cash721K93.1K774%
Total Debt40K1.63M2%
FUNDAMENTALS RATINGS
TDSGF vs USAQ: Fundamental Ratings
TDSGF
USAQ
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4456
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TDSGF's Valuation (49) in the null industry is in the same range as USAQ (52). This means that TDSGF’s stock grew similarly to USAQ’s over the last 12 months.

TDSGF's Profit vs Risk Rating (100) in the null industry is in the same range as USAQ (100). This means that TDSGF’s stock grew similarly to USAQ’s over the last 12 months.

TDSGF's SMR Rating (100) in the null industry is in the same range as USAQ (100). This means that TDSGF’s stock grew similarly to USAQ’s over the last 12 months.

TDSGF's Price Growth Rating (44) in the null industry is in the same range as USAQ (56). This means that TDSGF’s stock grew similarly to USAQ’s over the last 12 months.

TDSGF's P/E Growth Rating (100) in the null industry is in the same range as USAQ (100). This means that TDSGF’s stock grew similarly to USAQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TDSGFUSAQ
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
TDSGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WWD252.343.52
+1.41%
Woodward
EXK5.08N/A
N/A
Endeavour Silver Corp
MHH7.01-0.03
-0.43%
Mastech Digital
TALO8.67-0.12
-1.37%
Talos Energy
APLM6.14-0.42
-6.40%
Apollomics Inc

TDSGF and

Correlation & Price change

A.I.dvisor tells us that TDSGF and OPK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TDSGF and OPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TDSGF
1D Price
Change %
TDSGF100%
N/A
OPK - TDSGF
24%
Poorly correlated
+1.49%
PRPO - TDSGF
22%
Poorly correlated
+6.67%
EDTXF - TDSGF
20%
Poorly correlated
-1.82%
USAQ - TDSGF
10%
Poorly correlated
N/A
UEEC - TDSGF
6%
Poorly correlated
-6.81%
More

USAQ and

Correlation & Price change

A.I.dvisor tells us that USAQ and XVIPF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that USAQ and XVIPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To USAQ
1D Price
Change %
USAQ100%
N/A
XVIPF - USAQ
23%
Poorly correlated
N/A
ADMT - USAQ
21%
Poorly correlated
-6.20%
WUXIF - USAQ
13%
Poorly correlated
N/A
TDSGF - USAQ
10%
Poorly correlated
N/A
TCHBF - USAQ
7%
Poorly correlated
N/A
More